Tag: generic substitution
Prescriber Attitudes Toward NTI Drugs and Substitution
Prescribers remain cautious about substituting generic versions of narrow therapeutic index (NTI) drugs due to safety concerns, despite FDA assurances. Real-world data, state laws, and clinical experience shape ongoing debates over substitution practices.
How Generics Control Healthcare Drug Spending in the U.S.
Generics make up 90% of U.S. prescriptions but only 12% of drug spending, saving billions annually. Learn how they work, why they're underused, and how they're the most powerful tool for controlling healthcare costs.
Antiseizure Medications and Generic Substitution: Risks and Best Practices
Generic antiseizure medications can save money, but for narrow therapeutic index drugs like lamotrigine and carbamazepine, even small changes in absorption can trigger seizures. Learn the risks, who’s most vulnerable, and how to protect yourself.
Antitrust Issues in Generic Substitution: How Big Pharma Blocks Cheaper Drugs
Big Pharma uses legal tricks like product hopping and REMS abuse to block generic drugs, keeping prices high. Learn how antitrust enforcement is fighting back-and why it matters for your wallet.